SecBot SecBot
EFFECT ·Filed Apr 22, 2026

CLGN

CollPlant Biotechnologies Ltd
BEARISH
Impact 6/10
Horizonimmediate Processed6mo ago SEC9999999995-26-001268
IPO/offering going effective
Actionable Insight ▼ Bearish

Traders should anticipate potential downward pressure on CLGN shares as selling shareholders may begin offloading shares immediately. Monitor for warrant exercise activity, which would further dilute shares outstanding. The declining stock price since the initial filing suggests weakening market sentiment ahead of this unlock.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
CLGN ▼ -14.54% at T+60d
SHORT call ✓ call won +14.54% · α vs SPY +19.32% · entry $0.3920 → $0.3350
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
-8.93%
call +8.93% · α +8.53%
$0.3570
settled 6mo ago
T+5d
-3.06%
call +3.06% · α +3.12%
$0.3800
settled 6mo ago
T+20d
+7.14%
call -7.14% · α -3.98%
$0.4200
settled 5mo ago
T+60d
-14.54%
call +14.54% · α +19.32%
$0.3350
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

The SEC has declared effective CollPlant Biotechnologies Ltd's F-1 registration statement, enabling the resale of up to 3,296,000 ordinary shares by selling shareholders. This is not an IPO but a secondary offering of existing warrants and shares, with no proceeds going to the company.

Key Facts

  • SEC declared effective the F-1 registration (File No. 333-294738) on April 21, 2026
  • Registration covers resale of 3,296,000 ordinary shares by selling shareholders
  • Shares consist of 1,600,000 from Series A warrants, 1,600,000 from Series B warrants, and 96,000 from placement agent warrants, all issued February 6, 2026
  • Company will not receive proceeds from the resale, though it may receive funds if warrants are exercised on a cash basis
  • Last reported share price was $0.29 on April 14, 2026, down from $0.62 on March 27, 2026

Financial Impact

Potential overhang of 3,296,000 shares representing immediate dilution risk if warrants are exercised; current market value of shares at $0.29 is approximately $955,840

dilutionshare countmarket capitalization

Risk Factors

  • Immediate selling pressure from 3.3M share overhang
  • Further dilution if warrants are exercised on a cash basis

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001268
Document: 9999999995-26-001268-index.html9999999995-26-001268
Document: 9999999995-26-001268.txt9999999995-26-001268
21 reports for CLGN
Performance horizon
100% Hit rate @ T+1 8 of 8 directional calls Went positive at some point 8 of 8 best @ T+60▲ +25.17%May 29, 2026
Filters
Rows
Reports for CLGN — sortable, filterable
TypeNow
Oct 27, 2026
today
144
NEUTRAL ★ 2/10
$3.78awaiting T+1—$3.90 (+3.17%)
Oct 19, 2026
8d ago
3
NEUTRAL ★ 2/10
$3.88 $3.76▼ −3.22%▼ −3.75%$3.90 (+0.52%)
Oct 15, 2026
12d ago
6-K
BEARISH ★ 6/10
$3.68 $3.63▲ +1.49%▲ +0.39%$3.90 (−5.98%)
Oct 9, 2026
18d ago
6-K
BEARISH ★ 5/10
$4.02 $3.91▲ +2.74%▲ +2.72%$3.90 (+2.99%)
Oct 8, 2026
19d ago
SC 13G
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.90 (−1.76%)
Oct 8, 2026
19d ago
SC 13D/A
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.90 (−1.76%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 3/10
$3.39 $3.46▲ +2.06%▲ +2.30%$3.90 (+15.04%)
Sep 30, 2026
27d ago
6-K
BEARISH ★ 7/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.90 (−9.24%)
Sep 30, 2026
27d ago
Press Release
BEARISH ★ 5/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.90 (−9.24%)
Sep 24, 2026
4w ago
6-K
NEUTRAL ★ 4/10
$4.12 $4.25▲ +3.16%▲ +2.61%$3.90 (−5.34%)
Showing 10 of 21

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026